Mortality within the endovascular treatment in Stanford type B aortic dissections

Detalhes bibliográficos
Autor(a) principal: Fioranelli,Alexandre
Data de Publicação: 2011
Outros Autores: Razuk Filho,Álvaro, Castelli Júnior,Valter, Karakhanian,Walter, Godoy,José Maria Pereira de, Caffaro,Roberto Augusto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382011000200016
Resumo: BACKGROUND: Endovascular stent-graft repair of aortic dissections is a relatively new procedure, and although apparently less invasive, the efficacy and safety of this technique have not been fully established. OBJECTIVE: To evaluate mortality in patients with complicated Stanford type B aortic dissections submitted to endovascular treatment. METHODS: Clinical, anatomical, imaging and autopsy data of 23 patients with complicated type B aortic dissections were reviewed from November 2004 to October 2007. The main indications for transluminal thoracic stent-grafting included: persistent pain in spite of medical therapy, signs of distal limb ischemia, signs of aortic rupture, progression of aneurismal dilation of the descending aorta during follow-up (defined as a diameter &gt; 50 mm) and the diameter of descending thoracic aorta of 40mm or larger at the onset of aortic dissection. Data were analyzed statistically; all p-values were two-tailed and differences < 0.05 were considered to indicate statistical significance. Continuous variables were expressed as mean (± SD), and medians were compared by the Student's t test. Differences in categorical variables between the groups were analyzed by the Chi-square or Fisher's exact test. RESULTS: The procedure presented primary technical success in 82.6% of patients. Four patients (17.4%) had an incomplete proximal entry seal. Three patients (13%) died within 30 days of the procedure and eight patients (34.8%) died after 30 days. CONCLUSION: Endovascular correction of complicated Stanford type B aortic dissections is a feasible and effective treatment option.
id SBCCV-1_016e3f0a1146d9afb59ff5871a1b27ed
oai_identifier_str oai:scielo:S0102-76382011000200016
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Mortality within the endovascular treatment in Stanford type B aortic dissectionsStentsMortalityAortic Diseases/surgeryAneurysm, DissectingBACKGROUND: Endovascular stent-graft repair of aortic dissections is a relatively new procedure, and although apparently less invasive, the efficacy and safety of this technique have not been fully established. OBJECTIVE: To evaluate mortality in patients with complicated Stanford type B aortic dissections submitted to endovascular treatment. METHODS: Clinical, anatomical, imaging and autopsy data of 23 patients with complicated type B aortic dissections were reviewed from November 2004 to October 2007. The main indications for transluminal thoracic stent-grafting included: persistent pain in spite of medical therapy, signs of distal limb ischemia, signs of aortic rupture, progression of aneurismal dilation of the descending aorta during follow-up (defined as a diameter &gt; 50 mm) and the diameter of descending thoracic aorta of 40mm or larger at the onset of aortic dissection. Data were analyzed statistically; all p-values were two-tailed and differences < 0.05 were considered to indicate statistical significance. Continuous variables were expressed as mean (± SD), and medians were compared by the Student's t test. Differences in categorical variables between the groups were analyzed by the Chi-square or Fisher's exact test. RESULTS: The procedure presented primary technical success in 82.6% of patients. Four patients (17.4%) had an incomplete proximal entry seal. Three patients (13%) died within 30 days of the procedure and eight patients (34.8%) died after 30 days. CONCLUSION: Endovascular correction of complicated Stanford type B aortic dissections is a feasible and effective treatment option.Sociedade Brasileira de Cirurgia Cardiovascular2011-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382011000200016Brazilian Journal of Cardiovascular Surgery v.26 n.2 2011reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.1590/S0102-76382011000200016info:eu-repo/semantics/openAccessFioranelli,AlexandreRazuk Filho,ÁlvaroCastelli Júnior,ValterKarakhanian,WalterGodoy,José Maria Pereira deCaffaro,Roberto Augustoeng2011-08-25T00:00:00Zoai:scielo:S0102-76382011000200016Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2011-08-25T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Mortality within the endovascular treatment in Stanford type B aortic dissections
title Mortality within the endovascular treatment in Stanford type B aortic dissections
spellingShingle Mortality within the endovascular treatment in Stanford type B aortic dissections
Fioranelli,Alexandre
Stents
Mortality
Aortic Diseases/surgery
Aneurysm, Dissecting
title_short Mortality within the endovascular treatment in Stanford type B aortic dissections
title_full Mortality within the endovascular treatment in Stanford type B aortic dissections
title_fullStr Mortality within the endovascular treatment in Stanford type B aortic dissections
title_full_unstemmed Mortality within the endovascular treatment in Stanford type B aortic dissections
title_sort Mortality within the endovascular treatment in Stanford type B aortic dissections
author Fioranelli,Alexandre
author_facet Fioranelli,Alexandre
Razuk Filho,Álvaro
Castelli Júnior,Valter
Karakhanian,Walter
Godoy,José Maria Pereira de
Caffaro,Roberto Augusto
author_role author
author2 Razuk Filho,Álvaro
Castelli Júnior,Valter
Karakhanian,Walter
Godoy,José Maria Pereira de
Caffaro,Roberto Augusto
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Fioranelli,Alexandre
Razuk Filho,Álvaro
Castelli Júnior,Valter
Karakhanian,Walter
Godoy,José Maria Pereira de
Caffaro,Roberto Augusto
dc.subject.por.fl_str_mv Stents
Mortality
Aortic Diseases/surgery
Aneurysm, Dissecting
topic Stents
Mortality
Aortic Diseases/surgery
Aneurysm, Dissecting
description BACKGROUND: Endovascular stent-graft repair of aortic dissections is a relatively new procedure, and although apparently less invasive, the efficacy and safety of this technique have not been fully established. OBJECTIVE: To evaluate mortality in patients with complicated Stanford type B aortic dissections submitted to endovascular treatment. METHODS: Clinical, anatomical, imaging and autopsy data of 23 patients with complicated type B aortic dissections were reviewed from November 2004 to October 2007. The main indications for transluminal thoracic stent-grafting included: persistent pain in spite of medical therapy, signs of distal limb ischemia, signs of aortic rupture, progression of aneurismal dilation of the descending aorta during follow-up (defined as a diameter &gt; 50 mm) and the diameter of descending thoracic aorta of 40mm or larger at the onset of aortic dissection. Data were analyzed statistically; all p-values were two-tailed and differences < 0.05 were considered to indicate statistical significance. Continuous variables were expressed as mean (± SD), and medians were compared by the Student's t test. Differences in categorical variables between the groups were analyzed by the Chi-square or Fisher's exact test. RESULTS: The procedure presented primary technical success in 82.6% of patients. Four patients (17.4%) had an incomplete proximal entry seal. Three patients (13%) died within 30 days of the procedure and eight patients (34.8%) died after 30 days. CONCLUSION: Endovascular correction of complicated Stanford type B aortic dissections is a feasible and effective treatment option.
publishDate 2011
dc.date.none.fl_str_mv 2011-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382011000200016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382011000200016
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0102-76382011000200016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.26 n.2 2011
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126597563940864